Peptide directory

Find a peptide

Public profiles inside a larger governed registry

Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.

The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.

There are 51 full evidence profiles. "Complete profiles" is a stricter subset of them (12): Full profiles that pass every blocking completion check (published sources, a documented review of a source, chemistry, two regulatory records, linked conclusions and the narrative sections). A full evidence profile that is not yet complete has simply not passed every one of those checks.

Published profiles

Search profiles and sources

Compare peptides side by side →
Refine by category
Category

7 peptide records (2 full evidence profiles, 5 source-only records)

  • Somatostatin-analog chelator conjugate

    DOTATATE

    Source-only record3 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    3 published source records. Source publication does not imply scientific appraisal.

    Open sources for DOTATATE →
  • Somatostatin-analog chelator conjugate

    Edotreotide

    Source-only record3 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    3 published source records. Source publication does not imply scientific appraisal.

    Open sources for Edotreotide →
  • Somatostatin analog

    Lanreotide

    Peptide analog

    Developing

    Matched on: category

    Lanreotide is a synthetic cyclic octapeptide somatostatin analog with high affinity particularly for somatostatin receptor subtypes 2 and 5. Receptor activation suppresses growth-hormone secretion and multiple gastroenteropancreatic hormones and can exert antiproliferative effects in selected somatostatin-receptor-expressing neuroendocrine tumors. Depot and Autogel formulations provide prolonged exposure; approved indications and administration requirements vary by product and jurisdiction.

    • 25 published sources
    • 24 with study appraisals
    • no linked conclusions
    Evidence and record details

    Evidence integrity map

    Human 1Preclinical 0Durable IDs 7Open signals 1
    Publication state
    Published profile
    Verified source records
    25 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    2 published regulatory entries
    Research questions
    No open questions documented
    Evidence review date
    No documented human review recorded

    Source verification checks records; it does not itself approve scientific conclusions.

  • Somatostatin analog

    Octreotate

    Source-only record1 published sourceno study appraisals

    Published sources available; full evidence profile in development.

    1 published source records. Source publication does not imply scientific appraisal.

    Open sources for Octreotate →
  • Somatostatin analog

    Octreotide

    Peptide analog

    Developing

    Matched on: category

    Octreotide is a synthetic cyclic octapeptide analog of somatostatin with greater metabolic stability and longer action than endogenous somatostatin. It binds predominantly somatostatin receptor subtypes 2 and 5, suppressing growth hormone and several gastroenteropancreatic hormones and secretions; effects therefore vary by receptor expression, disease, route, and formulation. Immediate-release injection, depot injection, and delayed-release oral products have distinct pharmacokinetics and regulatory labeling.

    • 25 published sources
    • 25 with study appraisals
    • no linked conclusions
    Evidence and record details

    Evidence integrity map

    Human 1Preclinical 0Durable IDs 7Open signals 1
    Publication state
    Published profile
    Verified source records
    25 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    2 published regulatory entries
    Research questions
    No open questions documented
    Evidence review date
    No documented human review recorded

    Source verification checks records; it does not itself approve scientific conclusions.

  • Radiolabeled somatostatin-analog precursor

    Pentetreotide

    Source-only record3 published sourcesno study appraisals

    Published sources available; full evidence profile in development.

    3 published source records. Source publication does not imply scientific appraisal.

    Open sources for Pentetreotide →
  • Somatostatin analog

    Tyr3-octreotide

    Source-only record1 published sourceno study appraisals

    Published sources available; full evidence profile in development.

    1 published source records. Source publication does not imply scientific appraisal.

    Open sources for Tyr3-octreotide →
How the public directory relates to the 501-record Master Registry

master registry transparency

501 master records, with governance status shown explicitly

WPF-MASTER-REGISTRY-TRANSPARENCY-1.0
501
Master records
467
Governed records
34
Review-deferred
458
Eligible for literature search
9
Governed comparators

The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the literature-search cohort (identities whose published literature WPF searches for; it does not refer to obtaining or buying any product). Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.

Which number counts what

  • 501 master records: the known registry of peptide and comparator identities (a catalog, never assumed complete).
  • 405 directory records in the search above: 51 full evidence profiles plus 354 source-only records (identities with published, verified sources but no full profile). The 23 result pages hold 18 records each and are counted from this same list.
  • 51 full evidence profiles: the profiles in the JSON export and the structured data on this page.
  • The observation form’s peptide selector uses a separate, more permissive list of identities that can be reported on; it is not the directory and not the evidence corpus.
Explore the full Master Registry →
What the profile status labels mean

Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.

Recently updated public records

When each public profile record was last changed — not clinical or scientific activity.

Peptide Directory — World Peptide Foundation